ArticleEJNMMI research2016

Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of α3 integrin-expressing human tumors.

Wenwu Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.